c-Myb-dependent cell cycle progression and Ca2+ storage in cultured vascular smooth muscle cells

Circulation Research

Volumn 80, Issue 5, 1997, Pages 617-626

  Husain, Mansoor ^a,b   Bein, Kiflai ^b   Jiang, Lianwei ^b   Alper, Seth L ^a,b   Simons, Michael ^b   Rosenberg, Robert D ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Ca2+; cell cycle; oncogene

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CAFFEINE; CALCIUM ION; DEXAMETHASONE; FURA 2 ACETOXYMETHYL ESTER; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; DNA BINDING; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTO ONCOGENE; VASCULAR SMOOTH MUSCLE;

EID: 0030892525     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.5.617     Document Type: Article

References (44)

1. Weston KM. The myh genes. Semin Cancer Biol. 1990;1:371-382.
2. Calabretta B, Nicolaides NC. c-Myb and growth control. Crit Rev Eukaryot Gene Expr. 1992;2:225-235.
3. Thompson C, Challoner P, Neiman P, Groudine M. Expression of the c-myb protooncogene during cellular proliferation. Nature. 1986;319:374-380.
4. Reilly CF, Kindy MS, Brown KE, Rosenberg RD, Sonenshein GE. Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem. 1989;264:6990-6995.
5. Brown KE, Kindy MS, Sonenshein GE. Expression of the c-myb proto-oncogene in bovine vascular smooth muscle cells. J Biol Chem. 1992;267:4625-4630.
6. Gerwitz AM, Calabretta B. A c-myb antisense oligodeoxynucleotide inhibits normal human heamtopoiesis in vitro. Science. 1988;242:1303-1306.
7. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott WJ Jr, Potter SS. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 1991;65:677-689.
8. Anfossi G, Gerwitz M, Calabretta B. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc Natl Acad Sci U S A. 1989;86:3379-3383.
9. Badiani P, Corbella P, Kioussis D, Marvel J, Weston K. Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Dev. 1994;8:770-782.
10. Simons M, Rosenberg RD. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res. 1992;70:835-843.
11. Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg RD. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature. 1992;359:67-70.
12. Cogswell JP, Cogswell PC, Kuehl WM, Cuddihy AM, Bender TM, Engelke U, Marcu KB, Ting JP. Mechanism of c-myc regulation by c-Myb in different cell lineages. Mol Cell Biol. 1993;13:2858-2869.
13. Travali S, Ferber A, Reiss K, Sell C, Koniecki J, Calabretta B, Baserga R. Effect of the myb gene product on expression of the PCNA gene in fibroblasts. Oncogene. 1991;6:887-894.
14. Ku DH, Wen SC, Engelhard A, Nicolaides NC, Lipson KE, Marino TA, Calabretta B, c-myb transactivates cdc2 expression via Myb binding sites in the 5′-flanking region of the human cdc2 gene [published erratum appears in J Biol Chem. 1993;268:13010]. J Biol Chem. 1993;268:2255-2259.
15. Venturelli D, Travali S, Calabretta B. Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression. Proc Natl Acad Sci U S A. 1990;87:5963-5967.
16. Berridge MJ. Calcium signalling and cell proliferation. Bioessays. 1995;17:491-500.
17. Ghosh TK, Bian JH, Short AD, Rybak SL, Gill DL. Persistent intracellular calcium pool depletion by thapsigargin and its influence on cell growth J Biol Chem. 1991;266:24690-24697.
18. 2+ pool content is linked to control of cell growth. Proc Natl Acad Sci U S A. 1993;90:4986-4990.
19. Waldron RT, Short AD, Meadows JJ, Ghosh TK, Gill DL. Endoplasmic reticulum calcium pump expression and control of cell growth. J Biol Chem. 1994;269:11927-11933.
20. Waldron RT, Short AD, Gill DL. Thapsigargin-resistant intracellular calcium pumps: role in calcium pool function and growth of thapsigargin-resistant cells [published erratum appears in J Biol Chem. 1995;270:18710]. J Biol Chem. 1995;270:11955-11961.
21. Simons M, Morgan KG, Parker C, Collins E, Rosenberg RD. The proto-oncogene c-myb mediates an intracellular calcium rise during the late G1 phase of the cell cycle [published erratum appears in J Biol Chem. 1993;268:16082]. J Biol Chem. 1993;268:627-632.
22. Simons M, Hideao A, Salzman E, Rosenberg R. c-Myb affects intracellular calcium handling in vascular smooth muscle cells. Am J Physiol. 1995;37:C856-C868.
23. Burgess T, Fisher E, Ross S, Bready J, Qian Y-X, Bayewitch L, Cohen A, Herrera C, Hu S-F, Kramer T, Lott F, Martin F, Pierce G, Simonet L, Farrell C. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci U S A. 1995;92: 4051-4055.
24. Guvakova M, Yakubov L, Vlodavsky I, Tonkinson J, Stein C. Phosphothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J Biol Chem. 1995;270:2620-2627.
25. Villa AE, Guzman LA, Poptic EJ, Labhasetwar V, D'Souza S, Farrell CL, Plow EF, Levy RJ, DiCorleto PE, Topol EJ. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. Circ Res. 1995;76: 505-513.
26. Stein CA. Does antisense exist? Nat Med. 1995;1:1119-1121.
27. Simons M, Rosenberg RD, Edelman ER. . . . and surreal antisense? Nat Med. 1996;2:131-132. Letter.
28. Biedenkapp H, Borgemeyer U, Sippel AE, Klempnauer KH. Viral myb oncogene encodes a sequence-specific DNA binding activity. Nature. 1988;335:835-837.
29. Nakagoshi H, Nagase T, Kanei-Ishii C, Ueno Y, Ishii S. Binding of the c-myb proto-oncogene product to the simian virus 40 enhancer stimulates transcription. J Biol Chem. 1990;265:3479-3483.
30. Nomura T, Sakai N, Sarai A, Sudo T, Kanei-Ishii C, Ramsay RG, Favier D, Gonda TJ, Ishii S. Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper. J Biol Chem. 1993;268:21914-21923.
31. Ogata K, Hojo H, Aimoto S, Nakai T, Nakamura H, Sarai A, Ishii S, Nishimura Y. Solution structure of a DNA-binding unit of Myb: a helix-turn-helix-related motif with conserved tryptophans forming a hydrophobic core. Proc Natl Acad Sci U S A. 1992;89:6428-6432.
32. Ogata K, Morikawa S, Nakamura H, Sekikawa A, Inoue T, Kanai H, Sarai A, Ishii S, Nishimura Y. Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices. Cell. 1994;79:639-648.
33. Kanei-Ishii C, Macmillan EM, Nomura T, Sarai A, Ramsay RG, Aimoto S, Ishii S, Gonda TJ. Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc Natl Acad Sci U S A. 1992;89:3088-3092.
34. Favier D, Gonda TJ. Defection of proteins that bind to the leucine zipper motif of c-Myb. Oncogene. 1994;9:305-311.
35. Kanei-Ishii C, Yasukawa T, Morimoto RI, Ishii S. c-Myb-induced trans-activation mediated by heat shock elements without sequence-specific DNA binding of c-Myb. J Biol Chem. 1994;269: 15768-15775.
36. Reilly CF. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin. J Cell Physiol. 1990; 142:342-351.
37. Kimes BW, Brandt BL. Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res. 1976;98: 349-366.
38. Weiler-Guettler H, Aird WC, Husain M, Rayburn H, Rosenberg RD. Targeting of transgene expression to the vascular endothelium of mice by homologous recombination at the thrombomodulin locus. Circ Res. 1996;78:180-187.
39. - exchange in CHOP cells of defined transient transfection status. Am J Physiol. 1994;36: C845-C856.
40. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
41. Kojima I, Matsunaga H, Kurokawa K, Ogata E, Nishimoto I. Calcium influx: an intracellular message of the mitogenic action of insulin-like growth factor-I. J Biol Chem. 1988;263:16561-16567.
42. Pietrzkowski Z, Sell C, Lammers R, Ullrich A, Baserga R. Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell Biol. 1992;12:3883-3889.
43. Kojima I, Mogami H, Shibata H, Ogata E. Role of calcium entry and protein kinase C in the progression activity of insulin-like growth factor-I in Balb/c 3T3 cells. J Biol Chem. 1993;268:10003-10006.
44. Mogami H, Kojima I. Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells. Biochem Biophys Res Commun. 1993; 196:650-658.